The Company leases office and research and development facility spaces under non-cancelable operating leases for various terms through 2031. Certain lease agreements include renewal options, rent abatement periods, and rental increases throughout the term. As of June 30, 2026, the Company had operating right-of-use (“ROU”) assets of $2.0 million. As of June 30, 2026, total operating lease liabilities of $2.3 million were comprised of current lease liabilities of $0.9 million and non-current lease liabilities of $1.4 million. As of September 30, 2025, the Company had operating ROU assets of $2.6 million. As of September 30, 2025, total operating lease liabilities of $3.0 million were comprised of current lease liabilities of $0.9 million and non-current lease liabilities of $2.1 million.

The following table provides the components of lease cost recognized in the consolidated statements of operations and comprehensive income (loss) for the periods presented (amounts in thousands):


	Three Months Ended June 30,				Nine Months Ended June 30,
	2026		2025		2026		2025
Operating lease costs	$	235	$	190	$	669	$	556
Short-term lease costs	12		89		183		380
Variable lease costs	6		39		158		209
Total lease costs	$	253	$	318	$	1,010	$	1,145


	Nine Months Ended June 30,
	2026		2025
Right of use assets acquired under new operating leases	$	—	$	1,947
Cash paid for amounts included in the measurement of lease liabilities	$	780	$	1,960


	June 30, 2026		September 30, 2025
Weighted-average remaining lease term (years) - operating leases	3.6		4.0
Weighted-average discount rate - operating leases	7.8	%	7.8	%

Maturities of operating lease liabilities as of June 30, 2026 were as follows (amounts in thousands):


	Operating Leases
Remaining 2026	$	275
2027	979
2028	477
2029	314
2030	323
2031 and thereafter	286
Total lease payments	2,654
Less: amount representing interest	(354)
Present value of future lease payments	$	2,300